Evidence map›Paper›PMID 36538090›Full record

ArticleCurrent microbiology2022

Diversity of Myxobacteria Isolated from Indonesian Mangroves and Their Potential for New Antimicrobial Sources.

Senlie Octaviana, Gian Primahana, Tjandrawati Mozef, Luiz G A Borges, Dietmar H Pieper, Joachim Wink

Abstract read
In one paragraph

Article in Current microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Senlie OctavianaHelmholtz Center for Infection Research, Microbial Strain Collection, Braunschweig, Germany.
Gian PrimahanaMicrobial Drug, Helmholtz Center for Infection Research, Braunschweig, Germany.
Tjandrawati MozefResearch Center for Pharmaceutical Ingredients and Traditional Medicines BRIN, Cibinong, Jawa Barat, Indonesia.
Luiz G A BorgesMicrobial Interactions and Processes, Helmholtz Center for Infection Research, Braunschweig, Germany.
Dietmar H PieperMicrobial Interactions and Processes, Helmholtz Center for Infection Research, Braunschweig, Germany.
Joachim WinkHelmholtz Center for Infection Research, Microbial Strain Collection, Braunschweig, Germany. Joachim.Wink@helmholtz-hzi.de.ORCID http://orcid.org/0000-0001-9675-0276

Funding

Deutscher Akademischer Austauschdienst 91654412
6 · The paper itself

Abstract

Mangroves are unique intertidal ecosystems that provide ecological niches to different microbes, which play various roles in nutrient recycling and diverse environmental activities. The association between myxobacteria and mangroves are hitherto poorly understood. The aim of our study was to evaluate the myxobacterial community composition as well as isolate myxobacteria and to characterize the antimicrobial activity of myxobacteria isolates from Indonesian mangroves. Twenty-five cultivable myxobacteria were affiliated in six genera: Myxococcus, Corallococcus, Archangium, Chondromyces, Racemicystis and Nannocystis of the order Myxococcales based on partial 16S rRNA gene sequences. Thirteen crude extracts showed moderate activities against at least one of human pathogenic microorganisms. The crude extract of Racemicystis sp. strain 503MSO indicated a novel compound, which has not been reported in the database yet and the identification of this compound needs further study. The myxobacterial communities of three different sampling sites were analyzed using primers adapted for the myxobacteria group identification. The results showed that myxobacterial communities are more diverse than assumed. Therefore, our study has highlighted the importance of the mangrove habitat as promising harbor of myxobacteria as well as novel antimicrobial compounds with activity against pathogenic microorganisms.

Indexed as

Anti-Infective AgentsMyxococcalesEcosystemHumansIndonesiaPhylogenyRNA, Ribosomal, 16SSoil MicrobiologyAnti-Infective AgentsRNA, Ribosomal, 16S

Identifiers

PMID36538090
PMCPMC9768008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.